Chronic obstructive pulmonary disease
Conditions
Interventions
Experimental group :Bufei Formula granule+Salmeteroticasone powder
Control group :Bufei decoction+Salmeteroticasone powder
Sponsors
Nanfang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: It meets the diagnostic criteria of traditional Chinese and Western medicine for COPD, and is a stable patient, and TCM syndrome differentiation is lung-kidney qi deficiency type; 2: Between 18 and 75 years old 3: The pulmonary function grade was ? ~ ? 4: Subjects voluntarily participate in clinical trials and sign informed consent
Exclusion criteria
Exclusion criteria: 1: Patients allergic to the drugs used in this study. 2: tuberculosis, fungi, tumors, irritating gas and other factors caused by chronic cough, wheezing patients. 3: Patients with pneumothorax, pulmonary bulla and bleeding tendency. 4: Patients with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system and mental illness. 5: Pregnant and lactating women and those allergic to known ingredients of the drug in this study. 6: The patient has digestive disorders, malnutrition patients, physical weakness or dehydration patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| pulmonary function ;TCM Syndrome Effect ;CAT rating;6MWT ;Inflammatory factor levels;ESQ;Acute exacerbation; | — |
Countries
China
Contacts
Public ContactZhang Yong
Nanfang Hospital of Southern Medical University
Outcome results
None listed